|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.040 CNY | -0.79% |
|
-5.08% | -31.61% |
| 06-01 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| 05-07 | Beijing SL Pharmaceutical Gets China Regulatory Nod for Xinfer Drug | MT |
| Market Cap | 5.18B 764M 668M 618M 577M 1.08B 72.24B 1.09B 7.34B 2.86B 35.52B 2.87B 2.81B 123B | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 4.04B 596M 521M 482M 450M 844M 56.32B 850M 5.72B 2.23B 27.69B 2.24B 2.19B 96.19B | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.41% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.79% | ||
| 1 week | -5.08% | ||
| Current month | -14.29% | ||
| 1 month | -17.51% | ||
| 3 months | -13.55% | ||
| 6 months | -34.29% | ||
| Current year | -31.61% |
| 1 week | 4.81 |  | 5.17 |
| 1 month | 4.81 | | 6.14 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 10/04/2006 |
Li Ji
DFI | Director of Finance/CFO | 45 | 23/04/2023 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 10/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 10/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 23/04/2009 |
Yu Lin Chen
BRD | Director/Board Member | 81 | 10/04/2006 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11-04 | Buy | Director | 100 | 0.0000% | ||
| 28/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 27/10/25 | Sell | Director | 340,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.79% | -5.08% | -28.51% | -48.78% | 764M | |
| +0.32% | -2.41% | +44.49% | +140.80% | 983B | |
| +1.27% | -1.85% | +54.41% | +39.65% | 557B | |
| +6.25% | +3.80% | +24.13% | +67.39% | 406B | |
| +1.88% | -1.93% | +23.33% | +16.35% | 314B | |
| +1.75% | +1.55% | +29.46% | +18.11% | 273B | |
| +1.48% | +1.80% | +28.17% | +34.37% | 272B | |
| +1.42% | +8.58% | -32.46% | -44.07% | 203B | |
| +2.11% | -1.66% | +19.14% | +50.10% | 186B | |
| +0.90% | +0.46% | +15.09% | +59.86% | 155B | |
| Average | +1.66% | -1.34% | +17.72% | +33.38% | 335.11B | |
| Weighted average by Cap. | +1.75% | -2.22% | +31.68% | +64.72% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 660M 97.5M 85.2M 78.81M 73.55M 138M 9.21B 139M 936M 364M 4.53B 366M 358M 15.74B | 624M 92.07M 80.45M 74.42M 69.46M 130M 8.7B 131M 884M 344M 4.28B 346M 338M 14.86B |
| Net income | -74.07M -10.93M -9.55M -8.84M -8.25M -15.49M -1.03B -15.6M -105M -40.86M -508M -41.05M -40.16M -1.76B | -347M -51.26M -44.79M -41.43M -38.67M -72.59M -4.84B -73.13M -492M -192M -2.38B -192M -188M -8.27B |
| Net Debt | -1.98B -293M -256M -237M -221M -414M -27.66B -417M -2.81B -1.09B -13.6B -1.1B -1.07B -47.24B | -1.14B -168M -147M -136M -127M -239M -15.92B -240M -1.62B -630M -7.83B -633M -619M -27.2B |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/06/26 | 5.040 ¥ | -0.79% | 22,848,443 |
| 18/06/26 | 5.080 ¥ | +0.99% | 19,168,410 |
| 17/06/26 | 5.030 ¥ | -2.71% | 20,344,360 |
| 16/06/26 | 5.170 ¥ | -2.64% | 22,337,080 |
Net sales - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
